Rebranding Lipophilic Excipients

Ali, Shaukat; Karpynec, Nina
September 2012
Pharmaceutical Technology Europe;Sep2012, Vol. 24 Issue 9, p8
Trade Publication
The article focuses on the rebranding of lipophilic excipeints. It says that the pharmaceutical industry relies on excipient manufacturers to design and produce excipients suitable to the dosage form and active pharmaceutical ingredients (API). It states that several excipient manufacturers are streamlining the nomenclature, structure and functionality of excipients such as stabilizers. Moreover, the rebranding reduces complexity and promote products the merits of qualities and performances.


Related Articles

  • Recent Options for Phase 1 Formulation Development and Clinical Trial Material Supply. Kadri, Balaji V. // Pharmaceutical Technology;Aug2008 Supplement, p32 

    The article examines various methods of capsule filling which aim to improve preformulation properties, including active pharmaceutical ingredients (APIs) and binary blends. The APIs is the quickest method which offers the advantage of having little or no need for excipients, however, the method...

  • Manufacturing techniques and excipients used during the formulation of oil-in-water type nanosized emulsions for medical applications. Tamilvanan, Shunmugaperumal; Senthilkumar, Sudalaimuthu Ramachandran; baskar, Raj; Sekharan, Thenrajan Raja // Journal of Excipients & Food Chemicals;2010, Vol. 1 Issue 1, p11 

    Medically, the oil-in-water nanosized emulsions are used mainly as delivery carriers for lipophilic drug molecules which show therapeutic activity when administered via parenteral, ocular and transdermal routes. To extract multifunctional activities, the nanosized emulsions containing neutral,...

  • Rebranding Lipophilic Excipients. Ali, Shaukat; Karpynec, Nina // Pharmaceutical Technology;Sep2012, Vol. 36 Issue 9, p8 

    The article focuses on rebranding lipophilic excipients. The basis for rebranding with the same prefix is to identify molecules by structures, functions and the applications of choice; enable the company's brand products to be recognized; and to differentiate pharmaceutical excipients from other...

  • Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. Bharate, Sonali S.; Bharate, Sandip B.; Bajaj, Amrita N. // Journal of Excipients & Food Chemicals;2010, Vol. 1 Issue 3, p3 

    Studies of active drug/excipient compatibility represent an important phase in the preformulation stage of the development of all dosage forms. The potential physical and chemical interactions between drugs and excipients can affect the chemical nature, the stability and bioavailability of drugs...

  • Recent Advances and Patents in Solid Dispersion Technology. Iqbal, Babar; Ali, Asgar; Ali, Javed; Baboota, Sanjula; Gupta, Sonal; Dang, Shweta; Muhammad, Shadab; Sahni, Jasjeet K. // Recent Patents on Drug Delivery & Formulation;Sep2011, Vol. 5 Issue 3, p244 

    High lipophilicity and high lattice energy of drugs, which result in poor solubility are major real challenges in the pharmaceutical industry for the successful development and commercialization of suitable dosage forms. Therefore various formulation strategies like complexation, lipid based...

  • Application of microcalorimetry to the formulation study. Terada, K.; Masuda, T.; Yoshihashi, Y.; Yonemochi, E. // Journal of Thermal Analysis & Calorimetry;Sep2006, Vol. 85 Issue 3, p675 

    Isothermal microcalorimetry was used to evaluate excipient compatibility of solid dosage form. Oxybutynin hydrochloride and cefaclor were used as model drugs for compatibility test with excipients. The calorimetric data for compatibility test were compared with those of HPLC data. Evaluation of...

  • A REVIEW : COPROCESSED EXCIPIENTS. Desai, Ujwala; Chavan, Rohini; Mhatre, Priti; Chinchole, Ruchira // International Journal of Pharmaceutical Sciences Review & Resear;Jan/Feb2012, Vol. 12 Issue 2, p93 

    Excipients are all substances contained in a dosage form other than the active substance. In recent years drug formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain active pharmaceutical ingredients to be...

  • New pharmaceutical excipients in solid dosage forms - A review. Patel, Hardik; Shah, Viral; Upadhyay, Umesh // International Journal of Pharmacy & Life Sciences;2011, Vol. 2 Issue 8, p1006 

    The objective of a medicinal formulation development project is to deliver drug to the patient in the required amount, at the required rate, consistently within a batch, from batch to batch, and over the product's shelf life. To produce a drug substance in a final dosage form requires...

  • PS 9100:2002 Pharmaceutical Excipients -- An Updated GMP Standards for Excipients Suppliers. McCraight, Ashley; Moss, Steve // Pharmaceutical Technology Europe;Jan2003, Vol. 15 Issue 1, p31 

    Discusses the definition and significance of excipient manufacturing controls and standards. Background on the good manufacturing practices established by the Pharmaceutical Quality Group and other international bodies; Importance of implementing the correct excipient manufacturing controls and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics